Clinical trial
Progression Rate of Pseudoxanthoma Elasticum-associated Choroidal and Retinal Degeneration
NCT05662085 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Progression Rate of Pseudoxanthoma Elasticum-associated Choroidal and Retinal Degeneration
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- October 1, 2022
- Completion date
- October 31, 2025
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.